Prominent Stanford University Scientist and Cellular Reprogramming Innovator Will Oversee All Research for Turn Bio Français

Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, announced that Co-Founder Dr. Vittorio Sebastiano will become its head of research.